Showing results (271-280 of 297) with videos related to

Sort By:
Pageof 30
Annals of the Rheumatic Diseases|June 5, 2026
Composite outcome measures that successfully differentiate active treatments from placebo in psoriatic arthritis trials: a GRAPPA-OMERACT systematic review and network meta-analysisTommy K Annfeldt, Mina N Händel, Tobias Haugegaard, et al.
The Journal of Rheumatology|February 16, 2021
Proceedings of the 2020 GRAPPA Collaborative Research Network (CRN) MeetingCarmel Stober, Deepak R Jadon, April W Armstrong, et al.
The Lancet. Rheumatology|January 30, 2024
Efficacy of guselkumab on axial involvement in patients with active psoriatic arthritis and sacroiliitis: a post-hoc analysis of the phase 3 DISCOVER-1 and DISCOVER-2 studiesPhilip J Mease, Philip S Helliwell, Dafna D Gladman, et al.
Annals of the Rheumatic Diseases|August 6, 2013
Remission induction comparing infliximab and high-dose intravenous steroid, followed by treat-to-target: a double-blind, randomised, controlled trial in new-onset, treatment-naive, rheumatoid arthritis (the IDEA study)J L Nam, E Villeneuve, E M A Hensor, et al.
Arthritis Care & Research|December 21, 2016
Determinants of Patient-Physician Discordance in Global Assessment in Psoriatic Arthritis: A Multicenter European StudyCarole Desthieux, Benjamin Granger, Andra Rodica Balanescu, et al.
RMD Open|February 11, 2021
Guselkumab, an inhibitor of the IL-23p19 subunit, provides sustained improvement in signs and symptoms of active psoriatic arthritis: 1 year results of a phase III randomised study of patients who were biologic-naïve or TNFα inhibitor-experiencedChristopher T Ritchlin, Philip S Helliwell, Wolf-Henning Boehncke, et al.
Seminars in Arthritis and Rheumatism|May 8, 2023
Developing a core outcome set for foot and ankle disorders in rheumatic and musculoskeletal diseases: A scoping review and report from the OMERACT 2022 foot and ankle special interest group sessionLara S Chapman, Jennifer Jones, Anthony C Redmond, et al.
Seminars in Arthritis and Rheumatism|February 28, 2025
What outcomes are important to people with foot and ankle disorders in rheumatic and musculoskeletal diseases? An OMERACT qualitative interview study across four continentsLara S Chapman, Caroline A Flurey, Pamela Richards, et al.
Arthritis Care & Research|February 27, 2020
The Phenotype of Axial Spondyloarthritis: Is It Dependent on HLA-B27 Status?Laura C Coates, Xenofon Baraliakos, Francisco J Blanco, et al.
Annals of the Rheumatic Diseases|August 20, 2017
Cross-phenotype association mapping of the MHC identifies genetic variants that differentiate psoriatic arthritis from psoriasisJohn Bowes, James Ashcroft, Nick Dand, et al.
Pageof 30